In the intricate world of pharmaceutical manufacturing, understanding the specifications and applications of each chemical component is crucial. Cyclobutanebutanamide, β-amino-α-hydroxy-, hydrochloride (1:1), identified by CAS number 394735-23-0, is a prime example of a specialized pharmaceutical intermediate that plays a significant role in drug synthesis. As a key component in the production of Boceprevir, an important antiviral drug, its availability and quality are of utmost importance to pharmaceutical companies worldwide.

This compound, characterized as a white powder, is highly valued for its specific molecular structure, C8H17ClN2O2, and a molecular weight of 208.69. Its primary utility lies in its function as an intermediate in the preparation of Boceprevir, a vital therapeutic agent used in the treatment of Hepatitis C. The synthesis of such complex APIs necessitates intermediates with precisely controlled purity and stereochemistry, underscoring the need for meticulous manufacturing processes.

For procurement professionals and R&D scientists, knowing where to buy high-purity Cyclobutanebutanamide, β-amino-α-hydroxy-, hydrochloride (1:1) is a critical aspect of their supply chain strategy. Sourcing from a reputable manufacturer in China that specializes in pharmaceutical intermediates ensures access to materials meeting stringent quality benchmarks, such as a purity of ≥99%. This level of quality is essential to guarantee the efficacy and safety of the final API.

When evaluating potential suppliers, it is important to consider their technical capabilities, production capacity, and commitment to regulatory compliance. A strong supplier will be able to provide comprehensive documentation, including Certificates of Analysis (CoA) and Material Safety Data Sheets (MSDS), and offer technical support to assist with application-specific queries. Understanding the price point and the total cost of ownership, including logistics and quality assurance, is also a key part of the procurement decision.

The demand for high-quality pharmaceutical intermediates like CAS 394735-23-0 is driven by the continuous need for advanced therapeutics. By establishing strong partnerships with reliable manufacturers, pharmaceutical companies can ensure a steady flow of essential materials, facilitating efficient drug development and manufacturing. This proactive approach to sourcing is fundamental for navigating the complexities of the pharmaceutical supply chain and bringing critical medicines to market.